Exclusive Enteral Nutrition for Remissionof Crohn's Diseases After Surgery

Crohn Disease in Remission Clinical Trial

Official title:

Exclusive Enteral Nutrition for Remissionof Crohn's Diseases After Surgery

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05214430
• Other study ID #: jinlingH202001
• Status: Completed
• Phase: N/A
• Start date: January 1, 2020
• Est. completion date: July 31, 2023

Study information

• Verified date: October 2023
• Source: Jinling Hospital, China
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

For patients with Crohn's diseases undergoing surgery，whether postoperative exclusive enteral nutrition(EEN) could delay the endoscopic relapse needs exploration.The trial will investigate the efficacy of postoperative EEN for maintaining disease remission.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 84
• Est. completion date: July 31, 2023
• Est. primary completion date: July 31, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 60 Years

Eligibility

Inclusion Criteria:

• CD patients who undergoing bowel resection with anastomosis

Exclusion Criteria:

• patients who received stoma creation

Related Conditions & MeSH terms

• Crohn Disease
• Crohn Disease in Remission

Intervention

Other:
• 3 months exclusive enteral nutrition after surgery
patients underwent intestinal resection and anastomosis in this arm will given over 3 months exclusive enteral nutrition,and free diet after 3 months.

Locations

Country	Name	City	State
China	General Surgery Institute,Jinling Hospital,Nanjing,Jiangsu,China	Nanjing	Jiangsu

Sponsors (1)

Lead Sponsor	Collaborator
Jinling Hospital, China

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	postoperative endoscopic recurrence	over i2b of rutgeerts score	1 YEAR